Answers are grounded in this paper and cite their sources.
This research develops a novel nanoplatform combining STING agonists and photothermal therapy to enhance antitumor effects in triple-negative breast cancer, suggesting new therapeutic avenues.
The Stimulator of Interferon Genes (STING) pathway crucially modulates antitumor immunity and has therapeutic potential in aggressive triple-negative breast cancer (TNBC). Agonist-mediated STING activation triggers interferon-signaling cascades, which amplifies immune responses and enhances antitumor capabilities. Adjunctively, photothermal therapy (PTT) utilizes localized hyperthermia for tumor ablation and concurrently elicits immunogenic cell death (ICD), releases tumor-associated antigens, and activates acquired immune responses. We used an amphiphilic carrier material (PEI-GCP(Z)/mPEG) to coload cyanine dye (IR783) and the STING agonist (MSA-2), which self-assembled into the nanoparticle (PMI) and conferred three therapeutic advantages: (1) PTT-induced tumor-cell death and release of tumor-associated antigens; (2) STING agonist-based activation of innate immunity and enhanced dendritic cell maturation and antigen presentation; and (3) significantly improved cytotoxic T-lymphocyte responses with immune checkpoint blockade and nanoparticle-aided photothermal-immunotherapy. We evaluated the cellular synergistic antitumor effects in vitro. In a bilateral breast tumor model, after intravenous injection, PMI accumulated in tumors and induced significant ICD after laser irradiation, promoted antigen-presenting cell maturation, and activated cytotoxic T-cell antitumor-killing effects. PMI-anti-PD-L1 antibody blockade inhibited distant tumor growth through an excellent antitumor immune response. Combining STING pathway activation with PTT to achieve robust antitumor immunity offers an effective approach to TNBC therapy.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: